Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (33,953) $ (62,908)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 100,253 117,844
Impairment expense 0 16,654
Deferred income tax benefit (11,639) (15,490)
Amortization of deferred debt issuance costs 405 407
Stock-based compensation 8,405 5,968
Provision for credit losses 282 448
Loss on disposal of assets 40,500 39,875
Changes in operating assets and liabilities:    
Accounts receivable (65,244) 117,072
Other current assets 325 2,598
Inventories (747) 587
Prepaid expenses 6,027 4,741
Accounts payable 64,237 (97,380)
Accrued and other current liabilities 408 (11,996)
Accrued interest 0 (394)
Net cash provided by operating activities 109,259 118,026
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (87,700) (86,509)
Proceeds from sale of assets 2,151 4,330
Net cash used in investing activities (85,549) (82,179)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayments of borrowings 0 (130,000)
Payment of finance lease obligation 0 (30)
Repayments of insurance financing (5,473) 0
Proceeds from exercise of equity awards 3,365 0
Tax withholdings paid for net settlement of equity awards (5,773) (598)
Net cash used in financing activities (7,881) (130,628)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 15,829 (94,781)
CASH AND CASH EQUIVALENTS - Beginning of period 68,772 149,036
CASH AND CASH EQUIVALENTS - End of period $ 84,601 $ 54,255